Summary
PRA Health Sciences offers a range of pain models to assess pain perception and the efficacy of experimental analgesics in healthy volunteers and patient populations. PRA has been involved in conducting Phase I-IV studies in healthy volunteers and patients with various types of acute and chronic pain. Our Early Development Services (EDS) group has state-of-the-art Phase I facilities and equipment, as well as a broad expertise in pain studies and availability of a large network of pain specialists.
Register to download
Pain Studies at PRA Early Development Services
You may also be interested in:
resource
Opportunities in low-level radiocarbon microtracing: applications and new technology
14C-radiolabeled (radiocarbon) drug studies are central to defining the disposition of therapeutics in clinical development. Concerns over radiation,…
Fact Sheet
First-in-Human Drug Evaluation at PRA Health Sciences & The Revised EMA Guideline on Early Clinical Trials
In July 2017, the European Medicines Agency (EMA) published its revised guidance on first-in-human (FIH) and early clinical trials. The revision…
Poster
Predicting Screen Failure Rates of Human Abuse Potential Studies
Human Abuse Potential (HAP) studies are required for New Drug Approvals of all drugs that have a potential psychoactive effect. The steps of…